Pfizer PFE updated its yearly sales guidance for Comirnaty, the COVID-19 vaccine it developed with BioNTech BNTX, saying it now expects $13.5 billion in revenue…
breakingnow_w51jcqJanuary 31, 2023
A handful of acquisitions this week point to a more deal-friendly year for biopharma and biotech companies, though none has generated the kind of excitement…
breakingnow_w51jcqJanuary 13, 2023
Pfizer PFE, -2.20% is the latest pandemic stock to face questions about its long-term strategy as revenue from its COVID-19 vaccine and antiviral business starts…
breakingnow_w51jcqJanuary 5, 2023
